The 1997 American Diabetes Association Criteria Versus the 1985 World Health Organization Criteria for the Diagnosis of Abnormal Glucose Tolerance: Poor agreement in the Hoorn Study

OBJECTIVE Recently, the American Diabetes Association (ADA) introduced new diagnostic criteria. These new criteria are based on fasting plasma glucose levels, avoiding the burdensome oral glucose tolerance test (OGTT). We compared the 1997 ADA criteria with the 1985 World Health Organization (WHO) criteria with respect to the prevalence of diabetes and the cardiovascular risk profile in the population of the Hoorn Study. RESEARCH DESIGN AND METHODS The Hoorn Study is a population-based survey of 2,484 men and women, aged 50–75 years. An OGTT was performed and cardiovascular risk factors were determined in 2,378 subjects without known diabetes. Subjects were categorized according to both sets of diagnostic criteria. RESULTS Although the prevalence of diabetes was similar for both sets of criteria, 47 of 120 (39.2%) subjects who were diagnosed with diabetes according to the 1997 ADA criteria were not classified as having diabetes when using the 1985 WHO criteria. Similarly, of 285 subjects diagnosed with impaired fasting glucose by the 1997 ADA criteria, 195 (68.4%) were classified as having normal glucose tolerance by the 1985 WHO criteria. The overall agreement was poor (K 0.33; 95% CI 0.28−0.38). Subjects who were diagnosed as having diabetes by either set of criteria had an adverse cardiovascular risk profile, which was between the cardiovascular risk profiles of concordant normal and concordant diabetic subjects. CONCLUSIONS In this study, both sets of criteria diagnosed a similar number of diabetic subjects, but many of the subjects shifted between glucose intolerance categories. With either set of criteria, a considerable number of subjects at risk of developing diabetes and subjects carrying an increased risk of cardiovascular disease, as reflected by an adverse cardiovascular risk profile, will be missed.

[1]  J. Widimský,et al.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus , 1998, Diabetes Care.

[2]  K. Flegal,et al.  Comparison of Diabetes Diagnostic Categories in the U.S. Population According to 1997 American Diabetes Association and 1980–1985 World Health Organization Diagnostic Criteria , 1997, Diabetes Care.

[3]  E. Barrett-Connor Does Hyperglycemia Really Cause Coronary Heart Disease? , 1997, Diabetes Care.

[4]  Ralph B D'Agostino,et al.  Risk Variable Clustering in the Insulin Resistance Syndrome: The Framingham Offspring Study , 1997, Diabetes.

[5]  M. Engelgau,et al.  Comparison of Fasting and 2-Hour Glucose and HbA1c Levels for Diagnosing Diabetes: Diagnostic criteria and performance revisited , 1997, Diabetes Care.

[6]  R. Bain,et al.  Predictors of Progression From Impaired Glucose Tolerance to NIDDM: An Analysis of Six Prospective Studies , 1997, Diabetes.

[7]  M. Harris,et al.  Undiagnosed Diabetes or Impaired Glucose Tolerance and Cardiovascular Risk , 1997, Diabetes Care.

[8]  S. Haffner,et al.  The Insulin Resistance Syndrome Revisited , 1996, Diabetes Care.

[9]  H. Valkenburg,et al.  Prevalence and Determinants of Glucose Intolerance in a Dutch Caucasian Population: The Hoorn Study , 1995, Diabetes Care.

[10]  R. Hanson,et al.  Which Test for Diagnosing Diabetes? , 1995, Diabetes Care.

[11]  R. Klein Hyperglycemie and Microvascular and Macrovascular Disease in Diabetes , 1995, Diabetes Care.

[12]  R. Hanson,et al.  Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes , 1994, BMJ.

[13]  M. Harris,et al.  Fasting Plasma Glucose in Screening for NIDDM in the U. S. and Israel , 1994, Diabetes Care.

[14]  T. Orchard From Diagnosis and Classification to Complications and Therapy: DCCT Part II? , 1994, Diabetes Care.

[15]  T. Orchard,et al.  Diabetes Mellitus and Macrovascular Complications: An epidemiological perspective , 1992, Diabetes Care.

[16]  S. Haffner,et al.  Dyslipidemia in type II Diabetes: Implications for Therapeutic Intervention , 1991, Diabetes Care.

[17]  R. DeFronzo,et al.  Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease , 1991, Diabetes Care.

[18]  P. Zimmet,et al.  Determining Diabetes Prevalence: a Rational Basis for the Use of Fasting Plasma Glucose Concentrations? , 1990, Diabetic medicine : a journal of the British Diabetic Association.

[19]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[20]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[21]  H. Blackburn,et al.  Cardiovascular survey methods. , 1969, Monograph series. World Health Organization.

[22]  R. Hanson,et al.  Diagnosing diabetes mellitus – do we need new criteria? , 1997, Diabetologia.

[23]  P. Björntorp,et al.  Measurement of regional distribution of adipose tissue. , 1988 .